title: Validation of critical process input parameters in the production of protein pharmaceutical products: a strategy for validating new processes or revalidating existing processes.
authors.affiliation: Bayer Corporation, Berkeley, CA, USA.
authors.forename: S
authors.initials: S
authors.lastname: Martin-Moe
authors.forename: J
authors.initials: J
authors.lastname: Ellis
authors.forename: M
authors.initials: M
authors.lastname: Coan
authors.forename: R
authors.initials: R
authors.lastname: Victor
authors.forename: J
authors.initials: J
authors.lastname: Savage
authors.forename: N
authors.initials: N
authors.lastname: Bogren
authors.forename: B
authors.initials: B
authors.lastname: Leng
authors.forename: C
authors.initials: C
authors.lastname: Lee
authors.forename: M
authors.initials: M
authors.lastname: Burnett
authors.forename: P
authors.initials: P
authors.lastname: Montgomery
mesh_terms: D011506:Proteins; D013678:Technology, Pharmaceutical
chemical_list: D011506:Proteins